PAI-1 4G/5G Promoter Polymorphism

Description
Direct detection of a single base deletion at nucleotide -675 (4G/5G) in the promoter of the PAI-1 (SERPINE1) gene.
Clinical details
The presence of the single base deletion (4G/5G or 4G/4G) results in elevated levels of PAI-1 protein which can suppress fibrinolysis. Some studies have associated the 4G allele with an increased risk of thrombosis, MI, fetal loss and pre-eclampsia, although other studies dispute this. It is probable that only homozygosity (4G/4G) has any significance.
Related condition
Reference range

n/a

Units
n/a
Synonyms
PAI-1 SERPINE1 4G/5G
Testing site
Synnovis : Genomics : St Thomas' Hospital
Laboratory
Molecular Haemostasis
Sample type and volume required
1 x Edta
Call in advance
no
Storage and transport
transport at ambient temperature
Turnaround time
14 days
Contacts

Molecular Haemostasis Laboratory at St Thomas’ Hospital
Phone: 020 7188 2798
Haemostasis and Thrombosis
North Wing – 4th floor
St Thomas’ Hospital
Westminster Bridge Road
London SE1 7EH
Laboratory opening times
Monday – Friday 09.00 – 17.00

Last updated:

Back to search